Seagen Inc. (SGEN): Price and Financial Metrics
SGEN Price/Volume Stats
| Current price | $228.74 | 52-week high | $228.96 |
| Prev. close | $228.90 | 52-week low | $123.77 |
| Day low | $228.74 | Volume | 20,075,400 |
| Day high | $228.96 | Avg. volume | 1,478,439 |
| 50-day MA | $215.13 | Dividend yield | N/A |
| 200-day MA | $202.50 | Market Cap | 42.93B |
SGEN Stock Price Chart Interactive Chart >
Seagen Inc. (SGEN) Company Bio
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity. (Source:Wikipedia)
SGEN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 45.90% |
| 5-year | 98.63% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -16.88% |
| 2021 | -11.73% |
| 2020 | 53.28% |
| 2019 | 101.66% |
Continue Researching SGEN
Want to do more research on Seattle Genetics Inc's stock and its price? Try the links below:Seattle Genetics Inc (SGEN) Stock Price | Nasdaq
Seattle Genetics Inc (SGEN) Stock Quote, History and News - Yahoo Finance
Seattle Genetics Inc (SGEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...